Mohraz, Minoo; Vahdat, Katayoun; Ghamari, Seyyed-Hadi; … - In: The BMJ 382 (2023), pp. 1-12
To report the efficacy, safety, and exploratory immunogenicity findings of two 5 µg doses of the BIV1-CovIran vaccine. Randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial. In six cities of Iran, including Bushehr, Isfahan, Karaj, Mashhad, Shiraz, and Tehran. The...